Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Offers Jobs Courses Movies Merits
Sign In Sign Up
Theme Switcher
Night Mode
Sponsored
Roche’s HER2-Positive Breast Cancer Therapies: Expanding Leadership in Treatment
Expansion into the Adjuvant Setting Roche has reinforced its position in the HER2-positive breast cancer treatment market by entering the adjuvant therapy space. Approvals for PERJETA and HERCEPTIN in early-stage HER2-positive breast cancer have strengthened the company’s portfolio, offering improved patient outcomes. Combining PERJETA and HERCEPTIN with chemotherapy has become a key...
0 Comments ·0 Shares ·46 Views ·0 Reviews
Please log in to like, share and comment!
Sponsored
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
Sponsored
Sponsored